The latest closing stock price for Entrada Therapeutics as of May 16, 2025 is 8.09.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-662 today, roughly -1 times their original investment - a -23.76% compound annual growth rate over 4 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 21.79, which is 169.3% above the current share price.
The Entrada Therapeutics 52-week low stock price is 7.10, which is 12.2% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 14.55.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-662 today, roughly -1 times their original investment - a -23.76% compound annual growth rate over 4 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 21.79, which is 169.3% above the current share price.
The Entrada Therapeutics 52-week low stock price is 7.10, which is 12.2% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 14.55.